Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases
Neurological diseases (NDs) are a significant cause of disability and death in the global population. However, effective treatments still need to be improved for most NDs. In recent years, cell-membrane-coated nanoparticles (CMCNPs) as drug-targeting delivery systems have become a research hotspot....
Saved in:
Main Authors: | Jianzhuang Li (Author), Yanhao Wei (Author), Chunlin Zhang (Author), Rentang Bi (Author), Yanmei Qiu (Author), Yanan Li (Author), Bo Hu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of protein glycosylation in the occurrence and outcome of acute ischemic stroke
by: Jianzhuang Li, et al.
Published: (2023) -
Targeted delivery of rosuvastatin enhances treatment of hyperhomocysteinemia-induced atherosclerosis using macrophage membrane-coated nanoparticles
by: Dayue Liu, et al.
Published: (2024) -
Cell membrane coated-nanoparticles for cancer immunotherapy
by: Yingping Zeng, et al.
Published: (2022) -
Erythrocyte Membrane-Coated Arsenic Trioxide-Loaded Sodium Alginate Nanoparticles for Tumor Therapy
by: Yumei Lian, et al.
Published: (2019) -
Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy
by: Meiling Zhou, et al.
Published: (2018)